I now have a strong picture of the week. Let me look at the biggest names from the week-ahead tool results more carefully, filtering for the largest market caps:
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
I now have a strong picture of the week. Let me look at the biggest names from the week-ahead tool results more carefully, filtering for the largest market caps:
Big Earnings Week Ahead: Financials, Tech in Focus
The earnings calendar is packed for the week of May 4–9. Over 1,800 companies are set to report globally.
Today — Monday, May 5
Loews Corporation ($23B market cap) reports today. The diversified conglomerate covers insurance, energy, and hospitality. CNA Financial ($13B) also reports — it is a majority-owned Loews subsidiary. Back-to-back results from parent and subsidiary make today worth watching for insurance sector signals.
Corebridge Financial ($13B) posts its latest numbers after the close. The AIG spin-off has been under scrutiny for life insurance reserve trends.
BioMarin Pharmaceutical ($10B) holds an earnings call after the close.
Tuesday–Wednesday
Alkermes kicks off Tuesday. Flex Ltd. ($34B, Nasdaq) reports Wednesday alongside Cencora ($59B). Cencora is one of the largest US drug distributors. Its guidance on pharma pricing will be closely watched.
BorgWarner ($12B) reports Wednesday. Auto-parts investors want clarity on EV transition costs.
Albemarle ($23B) also reports Wednesday. The lithium giant's commentary on battery-metal demand will drive sector sentiment.
Thursday
Akamai Technologies ($15B) and Bentley Systems ($10B) headline Thursday. Callaway Golf reports after the close.
No major IPOs are scheduled in the next seven days per available data.
How this article was generated
- Generated
- 3 May 2026, 00:32
- Prompt version
- migrated
- Data sources
- EarningsAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.